VANDA PHARMACEUTICALS INC (VNDA) Stock Analyst Ratings
NASDAQ:VNDA - Nasdaq - US9216591084 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to VNDA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.64. This target is 137.41% above the current price.
VNDA was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VNDA.
In the previous month the buy percentage consensus was at a similar level.
VNDA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Initiate | Buy |
| 2024-08-01 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-07-11 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-02-25 | Jefferies | Downgrade | Buy -> Hold |
| 2021-05-12 | B of A Securities | Initiate | Buy |